Tawanda Gumbo MD
Mycobacterial Disease
Director of Research Programs in Global Health & Associate Professor of Medicine
Join to View Full Profile
UT Southwestern Medical Ctr5323 Harry Hines BLVDDallas, TX 75390
Phone+1 214-648-9914
Fax+1 214-648-2741
Dr. Gumbo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationFellowship, Infectious Disease, 1996 - 1999
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1993 - 1996
University of Zimbabwe Huggins SOMClass of 1991
Certifications & Licensure
TX State Medical License 2009 - 2018
Clinical Trials
- Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers Start of enrollment: 2009 Nov 01
Publications & Presentations
PubMed
- Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis.Vanessa B Vogensen, Sanjay Singh, Christopher J Allende, David M Engelthaler, Gunavanthi D Boorgula
Antimicrobial Agents and Chemotherapy. 2025-02-13 - Imipenem pharmacokinetics/pharmacodynamics in preclinical hollow fiber model, dose-finding in virtual patients, and clinical evidence of efficacy for Mycobacterium abs...Sanjay Singh, Tawanda Gumbo, Jann-Yuan Wang, Gunavanthi D Boorgula, Andrew Burke
The Journal of Infectious Diseases. 2024-12-17 - 1 citationsErtapenem's therapeutic potential for Mycobacterium avium lung disease in the hollow fibre model.Devyani Deshpande, Shashikant Srivastava, Tawanda Gumbo
International Journal of Antimicrobial Agents. 2024-09-01
Journal Articles
- Oxford University Press Has Registered This DOI Pre-PublicationTawanda Gumbo, MD, Oxford University Press
- Oxford University Press Has Registered This DOI Pre-PublicationTawanda Gumbo, Devyani Deshpande, Oxford University Press
- Oxford University Press Has Registered This DOI Pre-PublicationDevyani Deshpande, Tawanda Gumbo, Oxford University Press
- Join now to see all
Press Mentions
Praedicare Inc. Receives Grant to Evaluate Potential New Drug Regimens for TuberculosisJune 17th, 2021
New Tool for an Old Disease: Use of PET and CT Scans May Help Develop Shorter TB TreatmentFebruary 24th, 2020- New Tool for an Old Disease: Use of PET and CT Scans May Help Develop Shorter TB TreatmentFebruary 24th, 2020
- Join now to see all
Grant Support
- PK-PD Of Combination Antituberculosis Therapy For Suppression Of Drug-ResistanceNational Institute Of Allergy And Infectious Diseases2008–2011
- Efflux PUMP Inhibitors To Reduce Duration Of Antituberculosis TherapyOffice Of The Director, National Institutes Of Health2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
